Aptevo Therapeutics Inc.
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -9.92% | -10.77% | -7.61% | -11.60% | 3.72% |
| Total Depreciation and Amortization | -25.66% | -30.29% | -31.82% | -42.07% | -39.22% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.83% | -15.61% | -20.19% | 11.27% | -3.60% |
| Change in Net Operating Assets | 63.64% | -14.94% | 26.65% | -5.91% | -65.87% |
| Cash from Operations | -2.82% | -13.80% | -7.60% | -12.18% | -1.45% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.82% | 160.26% | 154.49% | 226.58% | 124.62% |
| Repurchase of Common Stock | -- | -- | -- | 100.00% | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.21% | -100.21% | -- | 15,833.33% | 15,833.33% |
| Cash from Financing | -1.01% | 152.39% | 146.85% | 230.70% | 128.89% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -71.21% | 252.71% | 257.57% | 217.17% | 110.39% |